市场调查报告书
商品编码
1499971
全球一次性组装市场评估:依产品、解决方案、应用、最终用途、地区、机会和预测(2017-2031)Single-Use Assemblies Market Assessment, By Product, By Solution, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
全球一次性组装市场规模预计将从 2023 年的 36.9 亿美元增至 2031 年的 127.2 亿美元,预计 2024-2031 年的复合年增长率为 16.73%。市场成长的推动因素包括製药和生物製药行业的快速成长、生物製品投资的增加、新产品和新技术的推出、加快药物开发进程的活动不断增加以及传染病的流行。
公司增加将药物快速推向市场的活动是全球一次性组装市场的主要趋势之一。 2024 年 4 月,SaniSure Limited 推出了 Fill4Sure,这是一种客製化的一次性填充组件,可提高药品填充流程的可重复性、安全性和效率。高性能管材、硅胶包覆成型、低颗粒 2D 缓衝袋、无黏合剂/无油 OEM 以及客製化设计的针头等功能可最大限度地降低污染风险并确保产品纯度。这些先进功能也简化了生物加工和生物製造流程,帮助製造商确保供应链安全并扩大生产能力。这些经济高效、量身定制的效率可帮助您轻鬆扩展规模,以满足行业不断变化的需求。
增加对生物製品的投资也预计将促进市场成长。 2024年1月,AbbVie宣布将投资2.23亿美元扩建其在新加坡的生物製剂生产设施。扩建预计于2026年完成,新增生物製剂产能24,000公升,并新增100个就业机会。该投资预计将支持该公司在全球扩张製造网络,并支持其癌症和免疫学产品线。此外,一次性组件也用于生物製药製造领域的各个阶段,包括中间製程储存、培养基和缓衝液製备、下游加工和上游加工。
研发活动的增加刺激了市场需求
全球各地区患有传染病和慢性病的患者数量不断增加,对需要一次性组装的疫苗的需求不断增加。这促使对疫苗生产的投资增加,以减少与传染病相关的有害影响,根除天花等严重病毒和病原体,并降低儿童死亡率。美国国立卫生研究院 (NIH) 等各种政府机构、慈善基金会以及比尔和梅琳达盖兹基金会和欧盟委员会等超国家机构也在资助疫苗研发活动。根据世界卫生组织(WHO)估计,2021年将供应1,410亿美元和约160亿剂疫苗。这些因素推动了对一次性组件的需求,因为它们透过减少清洁和停机时间来提高成本效率,并最大限度地降低因污染而导致产品损失的风险。
新产品的推出支持市场成长
增加开发有助于简化工作流程并实现快速部署的新产品的活动是全球一次性组装市场的关键成长动力之一。 2022 年 3 月,多佛公司推出了用于处理无菌液体的一次性液体生物处理袋。该公司还扩大了粉末(预填充和非预填充)和无菌液体产品的供应范围。该公司的供应声誉、全球足迹和品质确保其能够大规模、快速地满足客户不断变化的需求。
这些发展预计将透过提供根据客户独特需求量身定制的全面解决方案来增加全球一次性组装市场的需求。它们还透过提供易于部署且价格实惠的技术先进产品和创新解决方案,对市场成长产生积极影响。
本报告研究和分析了全球一次性组装市场,提供市场规模和预测、市场动态以及主要参与者的现状和前景。
Global single-use assemblies market is projected to witness a CAGR of 16.73% during the forecast period 2024-2031F, growing from USD 3.69 billion in 2023 to USD 12.72 billion in 2031F. The market's growth is augmented by the rapid growth of the pharmaceutical and biopharmaceutical sectors, increasing investments towards biologics, the introduction of novel products and technologies, growing efforts to expedite the drug development process, and the increasing prevalence of infectious diseases.
Rising efforts by companies to expedite drugs to market are among the major global single-use assembly market trends. In April 2024, SaniSure Limited launched Fill4Sure, a custom single-use filling assembly to increase drug product filling processes' repeatability, safety, and efficiency. Features such as high-performance tubing, silicone over-molding, low-particulate 2D surge bags, adhesive and oil-free OEM, and custom-designed needles ensure product purity by minimizing contamination risks. These advanced features also streamline bioprocessing and biomanufacturing processes, aiding the manufacturer in securing supply chains and expanding their capacity. Such cost-efficient and tailor-made efficiencies aid in effortless scaling up to meet the industry's evolving requirements.
Increasing investments in biologics are also expected to aid the market's growth. In January 2024, AbbVie Inc. announced an investment of USD 223 million to expand their Singapore biologics manufacturing facility. The expansion is expected to conclude in 2026 and add 24,000 liters of biologics drug-substance capacity and 100 new jobs. This investment is expected to aid the expansion of the company's manufacturing network globally and support its oncology and immunology pipeline. Additionally, single-use assemblies are used in various stages in the biologics manufacturing sector, including process-intermediate storage, media and buffer preparation, downstream processing, and upstream processing.
Increasing Research and Development Activities Boost Market Demand
The rise in infectious and chronic disease cases in various regions across the globe is propelling the requirement for vaccines, which require single-use assemblies. Due to this, the investments in the production of vaccines are increasing as they aid in reducing the detrimental effects associated with infectious diseases, eradicate major viruses and pathogens, such as smallpox, and decrease child mortality rates. Various government agencies such as the National Institute of Health (NIH), philanthropic foundations and supranational bodies, including the Bill and Melinda Gates Foundation and the European Commission, are also financing vaccine research and development activities. According to estimates from the World Health Organization (WHO), vaccines worth USD 141 billion, approximately 16 billion doses, were supplied in 2021. These factors boost the demand for single-use assemblies as they offer cost efficiency due to reduced cleaning and downtime and minimize the risk of product loss due to contamination.
New Product Launches Support Market Growth
Rising efforts to develop novel products that aid in streamlining workflow while allowing for rapid implementation are one of the major factors bolstering the global single-use assemblies market growth. In March 2022, Dover Corporation launched its liquid single-use bioprocessing bags for handling sterile liquids. The company is also expanding its powder (pre-filled and non-pre-filled) and sterile liquid offerings. Their supply reputation, global footprint, and quality ensure that they can meet the customers' evolving requirements at scale and speed.
Such developments are expected to propel the global single-use assemblies market demand as they allow companies to provide comprehensive solutions tailored to the customer's unique requirements. They also allow for the availability of technologically advanced products and ready-to-implement, affordable, and innovative solutions, thus positively influencing the market's growth.
North America Accounts for Significant Market Share
The market growth in North America is supported by the expansion of the pharmaceutical sector, increasing prevalence of infectious and chronic diseases, and rising emphasis on drug discovery research. Single-use assemblies find applications in patient delivery systems, cell cultivation, lab and drug discovery, and downstream and upstream bioprocessing.
The increasing awareness about the various advantages associated with using single-use assemblies as opposed to their counterparts is also supporting the expansion of the market in North America. Traditionally, process equipment is made of stainless steel, among other metals, and has high maintenance and upfront costs.
The rapid growth of the biotechnology industry in the United States is also expected to offer lucrative growth opportunities to the market as single-use assemblies find applications in various biotechnology domains, such as cell and gene therapy. According to estimates from the Council of State Bioscience Associations (CSBA) and Biotechnology Innovation Organization (BIO), the bioscience industry in the United States was valued at USD 2.9 trillion in 2021.
Pharmaceutical and Biopharmaceutical Companies Hold Significant Market Share
The rapid expansion of the pharmaceutical and biopharmaceutical sectors, owing to the increasing prevalence of various chronic and infectious diseases, supports the segment's growth. The increasing investments by major companies in developing new facilities to combat this growing threat bolstered the market's demand. Single-use assemblies reduce the risk of cross-batch and cross-product contamination and provide a smaller manufacturing footprint. Various sterile sectors, including pharmaceutical and biopharmaceutical sectors, have shifted to single-use assemblies and technologies at some time for a few applications, if not all, over the past few years as they aid in improving facility adaptability and flexibility and increase product integrity.
In February 2024, Thermo Fisher Scientific Inc. announced the opening of its new sterile drug facility in Singapore to ensure the delivery of new vaccines and medicines to the Asia Pacific market. The facility has been established with assistance from the Singapore Economic Development Board (EDB) and is in alignment with the efforts of the government to prepare for health emergencies that can emerge in the future. The increasing development of such facilities is expected to propel the requirement for single-use assemblies in the coming years, owing to their various advantages.
Future Market Scenario (2024-2031F)
According to the global single-use assemblies market analysis, the expansion of the pharmaceutical sector, coupled with increasing investments in research and development activities, is expected to bolster the market's demand in the coming years. Features such as reduced environmental impact, faster turnaround and changeover times, high flexibility, and reduced risk of product loss and cross-contamination are expected to propel the utilization of single-use assemblies in the coming years. Continuous efforts of key market players to enhance leak resistance and strength of single-use assemblies are also expected to provide lucrative growth opportunities to the market.
Key Players Landscape and Outlook
New launches by the key market players are bolstering the global single-use assemblies market size. In April 2023, Merck & Co., Inc. launched Ultimus films to provide leak resistance and superior strength in single-use assemblies used in bioprocessing liquid applications. The film is designed using a proprietary woven nylon structure to provide protection against fatigue, tears, leaks, and abrasion, as well as improved resilience and durability and enhanced bag strength. Incorporating woven nylon also provides ease of handling, conformity, and flexibility, which are essential for single-use processing. Such developments are expected to offer lucrative growth opportunities to the market in the coming years as they provide durable and stronger solutions to end-users while minimizing disruptions and increasing operational efficiency.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work